Diabetes Mellitus

(redirected from Non-Insulin Dependent Diabetes Mellitus)
Also found in: Dictionary, Thesaurus, Medical.

diabetes mellitus

[‚dī·ə′bēd·ēz ′mel·ə·dəs]
A metabolic disorder arising from a defect in carbohydrate utilization by the body, related to inadequate or abnormal insulin production by the pancreas.

Diabetes Mellitus


a chronic disease characterized by all kinds of metabolic disorders, chiefly carbohydrate, caused by the absolute or (more often) relative deficiency of the pancreatic hormone, insulin.

Heredity plays a major role in the origin of functional insufficiency of the islands of Langerhans of the pancreas, which produce insulin; the functional insufficiency may result from a trauma, inflammation, sclereosis of the pancreatic vessels, infections, intoxication, psychological trauma, excessive consumption of carbohydrates, and overeating in general. The functional condition of the other endocrine glands—the pituitary, adrenals, thyroid, and so forth—and the central and autonomic nervous systems is another factor. Because of the insulin deficiency the liver and muscles become unable to convert sugar into glycogen, and all the tissues lose their capacity to oxidize sugar and use it as an energy source. Moreover, glyconeogenesis also takes place —that is, sugar is formed from proteins and fats. As a result, sugar accumulates in the blood—to as much as 0.2-0.4 g per 100 milliliters of blood or more (hyperglycemia). When the amount of sugar in the blood is more than 0.18 g (“kidney threshold”), some of the sugar in the renal tubules is not reabsorbed and is excreted in the urine (glycosuria).

In more severe cases, liver function weakens, glycogen ceases to be synthesized and accumulates, and the products of protein and fat decomposition are no longer rendered harmless. As a result, a substantial quantity of ketone bodies, especially acetoacetic and /3- hydroxybutyric acids appear in the blood and then in the urine. The accumulation of these acids disturbs the acid-base equilibrium, causing acidosis. Acidosis may result in a diabetic coma.

Diabetes mellitus patients suffer from an intensified appetite and thirst (hunger and thirst may not be very intense in mild cases), increased excretion of urine (up to 5–8 liters a day) with a high specific gravity, itching of the skin and external genitalia, inflammation of the oral mucosa, pain along the nerve trunks (polyneuritis), and muscular and sexual weakness. The menstrual cycle is disturbed in women; spontaneous abortions or stillbirths may occur in pregnant women. The blood cholesterol level rises in diabetics, promoting the early onset of atherosclerosis, which is often combined with hypertonia. Marked changes in the cardiovascular system, kidneys, and eyes are among the serious complications of diabetes mellitus.

Treatment is individualized, taking into account the specific metabolic disorder. In mild forms, a special diet is prescribed, taking into account individual energy expenditures, and exercise therapy (especially for obese persons); in some cases, sugar-reducing sulfanilamide preparations (which are particularly effective in elderly persons with a tendency toward obesity) are prescribed. In moderate and severe forms insulin therapy is undertaken; long-acting insulin preparations with a sugar-reducing action are used to prolong the action of insulin.


Genes, S. G. Sakharnyi diabet, 5th ed. Moscow, 1963. (Bibliography.)
Diabet, edited by R. Williams. Moscow, 1964. (Translated from English; bibliography.)


References in periodicals archive ?
There are an estimated seven million patients in the United States who have been diagnosed with non-insulin dependent diabetes mellitus (NIDDM).
Type II non-insulin dependent diabetes mellitus (NIDDM) affects more than 100 million people worldwide.
These estimates, which include direct and indirect costs, reflect expenses incurred in connection with obesity-related non-insulin dependent diabetes mellitus, cardiovascular disease, gall bladder disease, cancer and musculoskeletal disorders.
28 /PRNewswire/ -- Several recent studies have shed new light on how weight loss can help individuals with non-insulin dependent diabetes mellitus reduce their blood glucose levels.
Weight loss has long been the initial prescription of choice for treatment of non-insulin dependent diabetes mellitus or NIDDM (when the individual with diabetes is overweight).
Sequana is collaborating with Glaxo Wellcome to identify the genes involved in adult-onset diabetes, or non-insulin dependent diabetes mellitus (NIDDM), as well as extreme human obesity.
Reaven will continue to focus his efforts on identification of compounds for Shaman's clinical programs, with a current focus on the company's eight new compounds for non-insulin dependent diabetes mellitus (NIDDM).
This product, now in its final phase of clinical trials, is designed for early diagnosis of Non-Insulin Dependent Diabetes Mellitus.
Osaka, Japan, today announced that they have entered into a three year collaboration agreement for the research and development of compounds for the treatment of non-insulin dependent diabetes mellitus (NIDDM).
The two major types of diabetes mellitus are insulin-dependent diabetes mellitus (IDDM or Type I, also called juvenile onset diabetes) and non-insulin dependent diabetes mellitus (NIDDM or Type II), which accounts for up to 95 percent of all cases.
is pleased to announce the successful completion of the first two of three phases of development of a new medical product designed for early diagnosis of non-insulin dependent Diabetes Mellitus which is approximately 60% of all diabetes cases.

Full browser ?